You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 276 No. 23, December 18, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (120)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Folic Acid Fortification of the Food Supply

Potential Benefits and Risks for the Elderly Population

Katherine L. Tucker, PhD; Brenda Mahnken, MSc; Peter W. F. Wilson, MD; Paul Jacques, ScD; Jacob Selhub, PhD

JAMA. 1996;276(23):1879-1885.


Abstract

Objective.
—To estimate the potential benefits and risks of food folic acid fortification for an elderly population. Benefits are expected through the improvement of folate and homocysteine status, but there is also a risk of masking or precipitating clinical manifestations related to vitamin B12 deficiency with increasing exposure to folic acid.

Desing.
—Cross-sectional analysis, with projected change at various levels of folic acid fortification.

Setting.
—Participants in the Framingham Heart Study original cohort.

Participants.
—A total of 747 subjects aged 67 to 96 years who both completed usable food frequency questionnaires and had blood concentrations of B vitamins and homocysteine measured.

Main Outcome Measures.
—Projected blood folate and homocysteine concentrations and combined high folate intake and low plasma vitamin B12 concentration.

Results.
—Percentages of this elderly population with folate intake below 400 µg/d are projected to drop from 66% at baseline to 49% with 140 µg of folate per 100 g of cereal-grain product, to 32% with 280 µg, to 26% with 350 µg, and to 11% with 700 µg. Percentages with elevated homocysteine concentrations (>14 µmol/ L) are projected to drop from 26% at baseline to 21% with 140 µg of folate per 100 g, to 17% with 280 µg, to 16% with 350 µg, and to 12% with 700 µg. Without fortification, the prevalence of combined high folate intake (>1000 µg/d) and low plasma vitamin B12 concentration (<185 pmol/L [<250 pg/mL]) was 0.1%. This is projected to increase to 0.4% with folate fortification levels of 140 to 350 µg/100 g and to 3.4% with 700 µg.

Conclusion.
—The evidence suggests that, at the level of 140 µg/100 g of cereal-grain product mandated by the Food and Drug Administration, the benefits of folate fortification, through projected decreases in homocysteine level and heart disease risk, greatly outweigh the expected risks. However, quantification of the actual risks associated with vitamin B12 deficiency remains elusive. Before higher levels of folic acid fortification are implemented, further research is needed to better understand the clinical course of various forms of vitamin B12 deficiency, to measure the potential effect of high folate intake on this course, and to identify cost-effective approaches to the identification and treatment of all forms of vitamin B12 deficiency.



Author Affiliations

From the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Mass (Drs Tucker, Jacques, and Selhub and Ms Mahnken), and the Framingham (Mass) Heart Study, National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Wilson).


Footnotes

The contents of this article do not necessarily reflect the views or policies of the US Department of Agriculture or the National Heart, Lung, and Blood Institute.

Reprints: Katherine L. Tucker, PhD, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St, Boston, MA 02111.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vitamin B12 and Folate and the Risk of Anemia in Old Age: The Leiden 85-Plus Study
den Elzen et al.
Arch Intern Med 2008;168:2238-2244.
ABSTRACT | FULL TEXT  

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of Inflammatory Markers to Predict Disease in Asymptomatic Patients: A Background Paper
Wilson
Circulation 2004;110:e568-e571.
ABSTRACT | FULL TEXT  

Folate Intake and Risk of Stroke Among Women
Al-Delaimy et al.
Stroke 2004;35:1259-1263.
ABSTRACT | FULL TEXT  

Plasma C-Reactive Protein and Homocysteine Concentrations Are Related to Frequent Fruit and Vegetable Intake in Hispanic and Non-Hispanic White Elders
Gao et al.
J. Nutr. 2004;134:913-918.
ABSTRACT | FULL TEXT  

Dietary Pattern Is Associated with Homocysteine and B Vitamin Status in an Urban Chinese Population
Gao et al.
J. Nutr. 2003;133:3636-3642.
ABSTRACT | FULL TEXT  

Polymorphism in the Thymidylate Synthase Promoter Enhancer Region Modifies the Risk and Survival of Colorectal Cancer
Chen et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:958-962.
ABSTRACT | FULL TEXT  

Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain
Mills et al.
Am. J. Clin. Nutr. 2003;77:1474-1477.
ABSTRACT | FULL TEXT  

Folate and risk of cardiovascular disease
Wald et al.
BMJ 2003;326:1035-1035.
FULL TEXT  

References
Circulation 2002;106:3373-3421.
FULL TEXT  

Elevated Serum Methylmalonic Acid Concentrations Are Common among Elderly Americans ,
Morris et al.
J. Nutr. 2002;132:2799-2803.
ABSTRACT | FULL TEXT  

Alcohol Dehydrogenase 3 Genotype Is Not Predictive for Risk of Colorectal Cancer
Chen et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:1303-1304.
FULL TEXT  

Folic Acid Fortification Increases Red Blood Cell Folate Concentrations in the Framingham Study
Choumenkovitch et al.
J. Nutr. 2001;131:3277-3280.
ABSTRACT | FULL TEXT  

Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond
Tice et al.
JAMA 2001;286:936-943.
ABSTRACT | FULL TEXT  

Prevention of Birth Defects: Folic Acid
Williamson
Biol Res Nurs 2001;3:33-38.
ABSTRACT  

Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use
Koehler et al.
Am. J. Clin. Nutr. 2001;73:628-637.
ABSTRACT | FULL TEXT  

Diet and Cancer: One View at the Start of the Millennium
Willett
Cancer Epidemiol. Biomarkers Prev. 2001;10:3-8.
ABSTRACT | FULL TEXT  

Potential Clinical and Economic Effects of Homocyst(e)ine Lowering
Nallamothu et al.
Arch Intern Med 2000;160:3406-3412.
ABSTRACT | FULL TEXT  

Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events
Booth et al.
CMAJ 2000;163:21-29.
ABSTRACT | FULL TEXT  

Folic acid: the opportunity that still exists
CMAJ 2000;162:1571-1572.
 

Cancer prevention and diet: Help from single nucleotide polymorphisms
Ames
Proc. Natl. Acad. Sci. USA 1999;96:12216-12218.
FULL TEXT  

A Polymorphism of the Methionine Synthase Gene: Association with Plasma Folate, Vitamin B12, Homocyst(e)ine, and Colorectal Cancer Risk
Ma et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:825-829.
ABSTRACT | FULL TEXT  

The Effect of Folic Acid Fortification on Plasma Folate and Total Homocysteine Concentrations
Jacques et al.
NEJM 1999;340:1449-1454.
ABSTRACT | FULL TEXT  

Modified Food Guide Pyramid for People over Seventy Years of Age
Russell et al.
J. Nutr. 1999;129:751-753.
FULL TEXT  

Prevention and Medicare Costs
Russell
NEJM 1998;339:1158-1160.
FULL TEXT  

Nutritional Folate Status Influences the Efficacy and Toxicity of Chemotherapy in Rats
Branda et al.
Blood 1998;92:2471-2476.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment
Stein and McBride
Arch Intern Med 1998;158:1301-1306.
ABSTRACT | FULL TEXT  

Reduction of Plasma Homocyst(e)ine Levels by Breakfast Cereal Fortified with Folic Acid in Patients with Coronary Heart Disease
Malinow et al.
NEJM 1998;338:1009-1015.
ABSTRACT | FULL TEXT  

Eat Right and Take a Multivitamin
Oakley
NEJM 1998;338:1060-1061.
FULL TEXT  

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Collaboration
BMJ 1998;316:894-898.
ABSTRACT | FULL TEXT  

Folate and Vitamin B6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women
Rimm et al.
JAMA 1998;279:359-364.
ABSTRACT | FULL TEXT  

Consequences of Hyperhomocyst(e)inemia on Vascular Function in Atherosclerotic Monkeys
Lentz et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2930-2934.
ABSTRACT | FULL TEXT  

Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage
Blount et al.
Proc. Natl. Acad. Sci. USA 1997;94:3290-3295.
ABSTRACT | FULL TEXT  

Folate Supplementation and the Risk of Masking Vitamin B12 Deficiency
Brantigan
JAMA 1997;277:884-884.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.